Regional Health Properties, Inc. (RHEP)
OTCMKTS · Delayed Price · Currency is USD
1.370
0.00 (0.00%)
Dec 1, 2025, 11:54 AM EST
RHEP Market Cap
RHEP has a market cap or net worth of $5.14 million as of December 1, 2025. Its market cap has increased by 58.37% in one year.
Market Cap
5.14M
Enterprise Value
76.19M
Revenue
37.30M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.37
Market Cap Chart
Since October 2, 2017, RHEP's market cap has decreased from 233.80M to 5.14M, a decrease of -97.80%. That is a compound annual growth rate of -37.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 5.14M | 74.81% |
| Dec 31, 2024 | 2.94M | -17.65% |
| Dec 29, 2023 | 3.57M | -38.01% |
| Dec 30, 2022 | 5.76M | -24.72% |
| Dec 31, 2021 | 7.65M | 27.59% |
| Dec 31, 2020 | 5.99M | 158.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 849.79M |
| Elite Pharmaceuticals | 571.69M |
| Glass House Brands | 486.41M |
| American Oncology Network | 429.20M |
| CytoDyn | 414.34M |
| Northwest Biotherapeutics | 394.75M |
| Silence Therapeutics | 318.36M |
| Nika Pharmaceuticals | 259.91M |